Codagenix utilises a breakthrough platform technology termed SAVE (Synthetic Attenuated Virus Engineering) to construct live-attenuated viral vaccines against multiple targets.
Location:
3 Bioscience Park Drive, Farmingdale, NY 11735-0176
Categories:
The Synthetic Genome
Founded in:
2009
Employee number:
10-100
Annual revenue:
$3.4M